Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial)

Fang Yu, Ulf G Bronas, Suma Konety, Nathaniel W Nelson, Maurice Dysken, Clifford Jack Jr, Jean F Wyman, David Vock, Glenn Smith, Fang Yu, Ulf G Bronas, Suma Konety, Nathaniel W Nelson, Maurice Dysken, Clifford Jack Jr, Jean F Wyman, David Vock, Glenn Smith

Abstract

Background: Alzheimer's disease, a global public health issue, accounts for 60 to 80% of all dementias. Alzheimer's disease primarily causes cognitive impairment and drugs have only modest short-term effects, highlighting a pressing need to develop effective interventions. Aerobic exercise holds promise for treating cognitive impairment in Alzheimer's disease through biologically sound mechanisms. Nonetheless, aerobic exercise studies in Alzheimer's disease are limited with mixed findings.

Methods/design: This pilot randomized controlled trial will investigate the effects of a 6-month, individualized, moderate-intensity cycling intervention (20 to 50 minutes per session, 3 times a week) on cognition and hippocampal volume in community-dwelling older adults with mild-to-moderate Alzheimer's disease. The specific aims are to: 1) determine the immediate effect of the cycling intervention on cognition in Alzheimer's disease; 2) examine if the cycling intervention slows cognitive decline in Alzheimer's disease from baseline to 12 months; and 3) assess the effect of aerobic exercise on hippocampal volume over 12 months. Ninety subjects will be randomized on a 2:1 allocation ratio to cycling or attention control (low-intensity stretching) and followed for another 6 months. Allocations will be concealed to all investigators and outcome assessors will be blinded to group assignments and previous data. Cognition will be measured by the Alzheimer's disease Assessment Scale-Cognition at baseline before randomization and at 3, 6, 9, and 12 months. Hippocampal volume will be measured by magnetic resonance imaging at baseline and 6 and 12 months. The sample size of 90 will give 80% power to detect a 2.5-point difference in within-group changes in the Alzheimer's disease Assessment Scale-Cognition at 6 months for the cycling group.

Discussion: Findings from this study will address the critical gap of exercise efficacy in Alzheimer's disease and use of magnetic resonance imaging as an outcome measure in clinical trials. This study will provide a potential treatment that may increase physical function and quality of life and curb the prohibitive costs for the growing dementia population.

Trial registration: Primary registration: (NCT01954550; date of registration: 20 September 2013). Secondary registration: (NCT01954550; date of registration: 1 October 2013).

Figures

Figure 1
Figure 1
Subject enrollment flow diagram.
Figure 2
Figure 2
Subject flow and timeline.

References

    1. World Health Organization . Dementia: a public health priority. 2012.
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (4th ed.) text revision (DSM-IV-TRTM) Washington, DC: American Psychiatric Association; 2000.
    1. Yu F, Kolanowski A, Strumpf N, Eslinger P. Improving cognition and function through exercise intervention in Alzheimer's disease. J Nurs Scholarsh. 2006;38(4):358–365. doi: 10.1111/j.1547-5069.2006.00127.x.
    1. Birks J. Cochrane Database Syst Rev. 2006. Cholinesterase inhibitors for Alzheimer’s disease.
    1. Adlard AP, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J of Neuroscience. 2004;25:4217–4221. doi: 10.1523/JNEUROSCI.0496-05.2005.
    1. Cotman CW, Berchtold NC. Physical activity and the maintenance of cognition: learning from animal models. Alzheimers Dement. 2007;3(Suppl 2):30–37. doi: 10.1016/j.jalz.2007.01.013.
    1. Erickson KI, Kramer AF. Aerobic exercise effects on cognitive and neural plasticity in older adults. Br J Sports Med. 2009;43(1):22–24. doi: 10.1136/bjsm.2008.052498.
    1. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Cochrane Database Syst Rev. 2008. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment.
    1. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14(2):125–130. doi: 10.1111/1467-9280.t01-1-01430.
    1. Etnier J, Salazar W, Landers D, Petruzzello S, Han M, Nowell P. The influence of physical fitness and exercise upon cognitive functioning: a meta-analysis. J Sport and Exerc Psychol. 1997;19(3):249–277.
    1. Etnier JL, Nowell PM, Landers DM, Sibley BA. A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res Rev. 2006;52(1):119–130. doi: 10.1016/j.brainresrev.2006.01.002.
    1. Smith P, Blumenthal J, Hoffman B, Cooper H, Strauman T, Welsh-Bohmer K, Sherwood A. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med. 2010;72(3):239–252. doi: 10.1097/PSY.0b013e3181d14633.
    1. Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Craft S. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol. 2010;67(1):71–79. doi: 10.1001/archneurol.2009.307.
    1. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil. 2004;85(10):1694–1704. doi: 10.1016/j.apmr.2004.03.019.
    1. Scherder E, Van Paasschen J, Deijen J, Van Der Knokke S, Orlebeke J, Burgers I, Sergeant J. Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Mental Health. 2005;9(3):272–280. doi: 10.1080/13607860500089930.
    1. Williams P, Lord SR. Effects of group exercise on cognitive functioning and mood in older women. Australian New Zealand J Public Health. 1997;21(1):45–52. doi: 10.1111/j.1467-842X.1997.tb01653.x.
    1. Rolland Y, Rival L, Pillard F, Lafont C, Rivére D, Albaréde J, Vellas B. Feasibility of regular physical exercise for patients with moderate to severe Alzheimer disease. J Nutr Health Aging. 2000;4(2):109–113.
    1. Palleschi L, Vetta F, De Gennaro E, Idone G, Scottosanti G, Gianni W, Marigliano V. Effect of aerobic training on the cognitive performance of elderly patients with senile dementia of Alzheimer type. Arch Gerontol Geriatrics. 1996;5:47–50. doi: 10.1016/0167-4943(96)86912-3.
    1. Yu F, Nelson NW, Savik K, Wyman JF, Dyskin M, Bronas UG. Affecting cognition and quality of life via aerobic exercise in Alzheimer's disease. West J Nurs Res. 2013;35(1):24–38. doi: 10.1177/0193945911420174.
    1. Yu F, Thomas W, Nelson NW, Bronas UG, Dysken M, Wyman J. J Appl Gerontol. 2013. Impact of a 6-month aerobic exercise on Alzheimer's symptoms.
    1. Kemoun G, Thibaud M, Roumagne N, Carette P, Albinet C, Toussaint L, Dugue B. Effects of a physical training programme on cognitive function and walking efficiency in elderly persons with dementia. Dementia Geriatric Cogn Disord. 2010;29(2):109–114. doi: 10.1159/000272435.
    1. Steinberg M, Leoutsakos JS, Podewils LJ, Lyketsos C. Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the maximizing independence in dementia (MIND) study. Int J Geriatric Psychiatry. 2009;24(7):680–685. doi: 10.1002/gps.2175.
    1. Arkin SM. Alzheimer rehabilitation by students: Interventions and outcomes. Neuropsychological Rehabilitation. 2001;11(3–4):273–317. doi: 10.1080/09602010143000059.
    1. Yu F. Guiding research and practice: a conceptual model for aerobic exercise training in Alzheimer's disease. Am J Alzheimers Dis Other Dementias. 2011;26(3):184–194. doi: 10.1177/1533317511402317.
    1. Arkin SM. Student-led exercise sessions yield significant fitness gains for Alzheimer's patients. Am J Alzheimers Disease Other Dementias. 2003;18(3):159–170. doi: 10.1177/153331750301800302.
    1. McCurry SM, Pike KC, Logsdon RG, Vitiello MV, Larson EB, Teri L. Predictors of short- and long-term adherence to a daily walking program in persons with Alzheimer's disease. A J Alzheimers Dis Other Dementias. 2010;25(6):505–512. doi: 10.1177/1533317510376173.
    1. Rolland Y, Pillard F, Klapouszczak A, Reynish E, Thomas D, Andrieu S, Vellas B. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc. 2007;55(2):158–165. doi: 10.1111/j.1532-5415.2007.01035.x.
    1. Tappen RM, Roach KE, Applegate EB, Stowell P. Effect of a combined walking and conversation intervention on functional mobility of nursing home residents with Alzheimer disease. Alzheimer Dis Assoc Disord. 2000;14(4):196–201. doi: 10.1097/00002093-200010000-00002.
    1. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, Larson EB. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. J Am Med Assoc. 2003;290(15):2015–2022. doi: 10.1001/jama.290.15.2015.
    1. Williams CL, Tappen RM. Effect of exercise on mood in nursing home residents with Alzheimer's disease. Am J Alzheimers Dis Other Dementias. 2007;22(5):389–397. doi: 10.1177/1533317507305588.
    1. Williams CL, Tappen RM. Exercise training for depressed older adults with Alzheimer's disease. Aging Mental Health. 2008;12(1):72–80. doi: 10.1080/13607860701529932.
    1. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259. doi: 10.1007/BF00308809.
    1. Jack CRJ, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998;51(4):993–999. doi: 10.1212/WNL.51.4.993.
    1. Jack CRJ, Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Members of the Alzheimer's Disease Cooperative Study (ADCS) Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging. 2008;29(9):1285–1295. doi: 10.1016/j.neurobiolaging.2007.03.004.
    1. Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Chui HC. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65(4):565–571. doi: 10.1212/01.wnl.0000172913.88973.0d.
    1. Fox NC, Kennedy J. Structural imaging markers for therapeutic trials in Alzheimer’s disease. J Nutr Health Aging. 2009;13(4):350–352. doi: 10.1007/s12603-009-0040-y.
    1. Frisoni GB, Delacourte A. Neuroimaging outcomes in clinical trials in Alzheimer's disease. J Nutr Health Aging. 2009;13(3):209–212. doi: 10.1007/s12603-009-0060-7.
    1. Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatr. 2005;162(4):676–682. doi: 10.1176/appi.ajp.162.4.676.
    1. Jack CRJ, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Weiner MW. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27(4):685–691. doi: 10.1002/jmri.21049.
    1. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, Rogers S. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatr. 2003;160(11):2003–2011. doi: 10.1176/appi.ajp.160.11.2003.
    1. Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Perhach JL. Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease. Alzheimers Dement. 2011;7(4):425–435. doi: 10.1016/j.jalz.2010.09.003.
    1. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, Kramer AF. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus. 2009;19(10):1030–1039. doi: 10.1002/hipo.20547.
    1. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kramer AF. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108(7):3017–3022. doi: 10.1073/pnas.1015950108.
    1. Larson EB, Wang L. Exercise, aging, and Alzheimer disease. Alzheimer Dis Assoc Disord. 2004;18(2):54–56. doi: 10.1097/01.wad.0000126615.70030.70.
    1. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;4:291–292.
    1. Welsh KA, Ballard E, Nash F, Raiford K, Harrell L. Issues affecting minority participation in research studies of Alzheimer disease. Alzheimer Dis Assoc Disord. 1994;8(Suppl 4):38–48. doi: 10.1097/00002093-199400000-00005.
    1. Doraiswamy PM, Kaiser L, Bieber F, Garman RL. The Alzheimer's disease assessment scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease. Alzheimer Dis Assoc Disord. 2001;15(4):174–183. doi: 10.1097/00002093-200110000-00003.
    1. Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther. 2010;2:34. doi: 10.1186/alzrt58.
    1. Alzheimer's Association . Alzheimer's disease facts and figures. 2013.
    1. American College of Sports Medicine . ACSM's Guidelines for Exercise Testing and Prescription (9th ed.) Baltimore, MD: Lippincott Williams and Wilkins; 2013.
    1. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Treatment Fidelity Workgroup of the NIH Behavior Change Consortium Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004;23(5):443–451. doi: 10.1037/0278-6133.23.5.443.
    1. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatr. 1984;141(11):1356–1364. doi: 10.1176/ajp.141.11.1356.
    1. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. segmentation and surface reconstruction. NeuroImage. 1999;9(2):179–194. doi: 10.1006/nimg.1998.0395.
    1. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97(20):11050–11055. doi: 10.1073/pnas.200033797.
    1. Jack CRJ, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Foster NL. Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement. 2011;7(4):474–485. doi: 10.1016/j.jalz.2011.04.007.
    1. Fox NC, Warrington EK, Rossor MN. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet. 1999;353(9170):2125. doi: 10.1016/S0140-6736(99)00496-1.
    1. Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging. 1997;16(5):623–629. doi: 10.1109/42.640753.
    1. Gunter JL, Shiung MM, Manduca A, Jack CR. Methodological considerations for measuring rates of brain atrophy. J Magn Reson Imaging. 2003;18(1):16–24. doi: 10.1002/jmri.10325.
    1. Jack CRJ, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Petersen RC. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004;62(4):591–600. doi: 10.1212/01.WNL.0000110315.26026.EF.
    1. Jack CRJ, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Petersen RC. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65(8):1227–1231. doi: 10.1212/01.wnl.0000180958.22678.91.
    1. Royall DR, Mahurin RK, Gray KF. Bedside assessment of executive cognitive impairment: the executive interview. J Am Geriatr Soc. 1992;40(12):1221–1226. doi: 10.1111/j.1532-5415.1992.tb03646.x.
    1. Grigsby J, Kaye K, Robbins LJ. Reliabilities, norms and factor structure of the behavioral dyscontrol scale. Percept Motor Skills. 1992;74(3):883–892. doi: 10.2466/pms.1992.74.3.883.
    1. Royall DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 1998;64(5):588–594. doi: 10.1136/jnnp.64.5.588.
    1. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Morris JC. The Alzheimer's disease centers' uniform data set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009;23(2):91–101. doi: 10.1097/WAD.0b013e318191c7dd.
    1. Burns JM, Mayo MS, Anderson HS, Smith HJ, Donnelly JE. Cardiorespiratory fitness in early-stage Alzheimer disease. Alzheimer Dis Assoc Disord. 2008;22(1):39–46. doi: 10.1097/WAD.0b013e31815a9ddc.
    1. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–1024. doi: 10.1136/thx.47.12.1019.
    1. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119(1):256–270. doi: 10.1378/chest.119.1.256.
    1. McAuley E, Morris KS, Doerksen SE, Motl RW, Liang H, White SM, Rosengren K. Effects of change in physical activity on physical function limitations in older women: Mediating roles of physical function performance and self-efficacy. J Am Geriatr Soc. 2007;55(12):1967–1973. doi: 10.1111/j.1532-5415.2007.01469.x.
    1. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–M94. doi: 10.1093/geronj/49.2.M85.
    1. Gelinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999;53(5):471–481. doi: 10.5014/ajot.53.5.471.
    1. Cummings J. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(Suppl 5):10–16. doi: 10.1212/WNL.48.5_Suppl_6.10S.
    1. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatr Clin Neurosci. 2000;12(2):233–239. doi: 10.1176/jnp.12.2.233.
    1. Tappen RM, Williams CL. Development and testing of the Alzheimer's disease and related dementias mood scale. Nurs Res. 2008;57(6):426–435. doi: 10.1097/NNR.0b013e31818c3dcc.
    1. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–284. doi: 10.1016/0006-3223(88)90038-8.
    1. The Psychological Corporation . Wechsler Test of Adult Reading. New York: The Psychological Corporation; 2001.
    1. Washburn R, Smith K, Jette A, Janney CA. The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46(2):153–162. doi: 10.1016/0895-4356(93)90053-4.
    1. Washburn R, McAuley E, Katula J, Mihalko S, Boileau R. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52:643–651. doi: 10.1016/S0895-4356(99)00049-9.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa